[1]Prasad S, Chen J. What You need to know
about AQP4, MOG, and NMOSD[J].
Semin Neurol, 2019(39): 718-731.
[2]Azimian
M, Arian M, Shojaei SF, et al. The effectiveness of group hope therapy training
on the quality of life and meaning of life in patients with multiple sclerosis
and their family caregivers[J].
Iran J Psychiatry 2021, 16(3): 260-270.
[3]Rocca
MA, Battaglini M, Benedict RH, et al. Brain MRI atrophy quantification in MS
from methods to clinical application[J]. Neurology, 2017, 88(24): 403-413.
[4]Matthews
L, Marasco R, Jenkinson M, et al. Distinction of seropositive NMO spectrum
disorder and MS brain lesion distribution[J]. Neurology, 2013,80(14): 1330-1337.
[5]Ashburner
J, Friston KJ. Voxel-based morphometry-the methods[J]. Neuroimage, 2000, 11(6pt 1): 805-821.
[6]Li RCh,
Tang J, Yang YF, et al. Volume changes of cerebral gray matter in patients with
obsessive-compulsive disorder ——morphological analysis
based on voxel[J]. Acta
Anatomica Sinica, 2021, 52(5): 692-697. (in Chinese)
李若川, 唐洁, 杨勇锋, 等. 强迫症患者大脑灰质体积变化 ———基于体素的形态学分析[J]. 解剖学报, 2021, 52(5): 692-697.
[7]Goto M,
Abe O, Hagiwara A, et al. Advantages of using both voxel-and surface-based
morphometry in cortical morphology analysis: a review of various applications[J]. Magn Reson Med Sci, 2022, 21(1): 41-57.
[8]Prinster
A, Quarantelli M, Lanzillo R, et al. A voxel-based morphometry study of disease
severity correlates in relapsing-remitting multiple sclerosis[J]. Mult Scler, 2010, 16(1): 45-54.
[9]Zhang
X, Zhang F, Huang D, et al. Contribution of gray and white matter abnormalities
to cognitive impairment in multiple sclerosis[J]. Int J Mol Sci, 2016, 18(1): 1-13.
[10]Eshaghi
A, Marinescu RV, Young AL, et al. Progression of regional grey matter atrophy
in multiple sclerosis[J].
Brain, 2018, 141(6): 1665-1677.
[11]Steenwijk
MD, Geurts JJ, Daams M, et al. Cortical atrophy patterns in multiple sclerosis
are non-random and clinically relevant[J]. Brain, 2016, 139(1): 115-126.
[12]Von
Glehn F, Jarius S, Cavalcanti Lira RP, et al. Structural brain abnormalities
are related to retinal nerve fiber layer thinning and disease duration in
neuromyelitis optica spectrum disorders[J]. Mult Scler, 2014, 20(9): 1189-1197.
[13]Sanchez-Catasus
CA, Cabrera-Gomez J, Almaguer Melian W, et al. The number of optic neuritis
attacks is a potential confounder when comparing patients with NMO vs. controls
by voxel-based neuroimaging analysis[J]. Acta Radiol, 2016, 57(8): 985-991.
[14]Calabrese
M, Oh MS, Favaretto A, et al. No MRI evidence of cortical lesions in
neuromyelitis optica[J].
Neurology, 2012, 79(16): 1671-1676.
[15]Pichiecchio
A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of
neuromyelitis optica: a multiparametric approach[J]. Mult Scler, 2012, 18(6): 817-824.
[16]Wang
T, Lian Z, Wu X, et al. Subcortical structural abnormalities in female
neuromyelitis optica patients with neuropathic pain[J]. Mult Scler Relat Disord, 2020, 37: 101432.
[17]Liu Y,
Xie T, He Y, et al. Cortical thinning correlates with cognitive change in
multiple sclerosis but not in neuromyelitis optica[J]. Eur Radiol, 2014, 24(9): 2334-2343.
[18]Duan
Y, Liu Y, Liang P, et al. Comparison of grey matter atrophy between patients
with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry
study[J]. Eur J Radiol, 2012,
81(2): 110-114.
[19]Pudlac
A, Burgetova A, Dusek P, et al. Deep gray matter iron content in neuromyelitis
optica and multiple sclerosis[J]. Biomed Res Int, 2020, 2020: 6492786.
[20]Minagar
A, Barnett MH, Benedict RH, et al. The thalamus and multiple sclerosis: modern
views on pathologic, imaging, and clinical aspects[J]. Neurology, 2013, 80(2): 210-219.
[21]Schoonheim
MM, Popescu V, Rueda Lopes FC, et al. Subcortical atrophy and cognition: sex
effects in multiple sclerosis[J]. Neurology, 2012, 79(17): 1754-1761.
[22]Lansley
J, Mataix-Cols D, Grau M, et al. Localized grey matter atrophy in multiple
sclerosis: a meta-analysis of voxel-based morphometry studies and associations
with functional disability[J].
Neurosci Biobehav Rev, 2013, 37(5): 819-830.
[23]Solana
E, Martinez-Heras E, Montal V, et al. Regional grey matter microstructural
changes and volume loss according to disease duration in multiple sclerosis
patients[J]. Sci Rep, 2021,
11(1): 1-11.
[24]Benedict
RH, Hulst HE, Bergsland N, et al. Clinical significance of atrophy and white
matter mean diffusivity within the thalamus of multiple sclerosis patients[J]. Mult Scler, 2013, 19(11): 1478-1484.
[25]Magon S, Chakravarty MM, Amann M, et al.
Label-fusion-segmentation and deformation-based shape analysis of deep gray
matter in multiple sclerosis: the impact of thalamic subnuclei on disability[J]. Hum Brain Mapp, 2014, 35(8): 4193-4203. |